ロード中...
Skin toxicity in BRAF(V600) mutated metastatic cutaneous melanoma patients treated with vemurafenib
INTRODUCTION: The use of orally available BRAF kinase inhibitor – vemurafenib is associated with numerous adverse skin reactions. AIM: To assess the safety and early side effects of vemurafenib treatment in the unselected group of patients treated at the outpatient clinic, in particular the assessme...
保存先:
| 出版年: | Postepy Dermatol Alergol |
|---|---|
| 主要な著者: | , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
Termedia Publishing House
2016
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4793055/ https://ncbi.nlm.nih.gov/pubmed/26985180 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.5114/pdia.2015.48045 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|